Stay updated on Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page's metadata. The change does not alter any study information or content presented to users.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange Detected- The page's revision label was updated from v3.5.3 to v3.5.4, indicating a backend or documentation update behind the scenes. - No substantive changes to the study details or visible content are implied by this revision.SummaryDifference0.0%

- Check42 days agoChange DetectedA new publication reference was added under Publications, citing a 2026 online-ahead-of-print article by Paller et al. on clinical laboratory parameters in adolescents with moderate-to-severe atopic dermatitis treated with tralokinumab in ECZTRA 6. This entry expands the study's related literature linked to ECZTRA 6.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page’s displayed software/site release revision is updated from v3.5.2 to v3.5.3 at the bottom of the page, indicating a minor platform/version change rather than any change to the trial information.SummaryDifference0.0%

- Check56 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a backend release update with no user-facing changes to study details.SummaryDifference0.0%

Stay in the know with updates to Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab for Adolescent Atopic Dermatitis Clinical Trial page.